NYSE:THCHealthcare
Tenet Healthcare (THC) Valuation Check After Earnings Beat Guidance Upgrade And Ongoing Buybacks
Tenet Healthcare (THC) has been in focus after fourth quarter 2025 results topped revenue and profit expectations, paired with 2026 guidance that points to higher adjusted EBITDA and continued share repurchases.
See our latest analysis for Tenet Healthcare.
The latest earnings beat, 2026 guidance and ongoing buybacks have arrived after a strong run, with a 19.8% 3 month share price return and a very large 5 year total shareholder return. This suggests momentum has been building rather than...